Case-control study evaluating competing risk factors for angioedema in a high-risk population

Rebecca J. Kamil, Elina Jerschow, Patricia A. Loftus, Melin Tan, Marvin P. Fried, Richard V. Smith, David Foster, Thomas J. Ow

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Objectives/Hypothesis: Black race is a risk factor for angioedema. The primary aim was to examine the relationship between race–ethnicity and risk factors for angioedema. Study Design: Using a retrospective case-control study design, data was extracted with the Clinical Looking Glass utility, a data collection and management tool that captures data from electronic medical record systems within the Montefiore Healthcare System. Cases were emergency department (ED) visits with primary or secondary International Classification of Diseases, Ninth Revision, code diagnoses of angioedema in adults aged ≥ 18 years from January 2008 to December 2013 at three Montefiore centers in Bronx, New York. Controls were a random sampling of adult ED visits during the same period. Methods: In primary analyses, angiotensin-converting enzyme inhibitor (ACE-I) and black race were evaluated for synergy. The influence of different risk factors in the development of angioedema was evaluated using logistic regression models. Finally, race–ethnicity was further explored by evaluating for effect modification by stratification of models by race–ethnicity categories. Results: There were 1,247 cases and 6,500 controls randomly selected from a larger control pool. ACE-I use (odds ratio [OR] 3.70, 95% confidence interval [CI] 2.98, 4.60), hypertension (OR 1.88, 95% CI 1.55, 2.29), and black race (OR 2.25, 95% CI 1.86, 2.72) were the strongest risk factors. ACE-I use and black race were not synergistic (OR 1.10, 95% CI 0.80, 1.51). Race–ethnicity was an effect modifier for certain risk factors. Conclusion: Race–ethnicity acts as an effect modifier for particular angioedema risk factors. The two strongest risk factors, ACE-I use and black race, were not synergistic. Level of Evidence: 3b. Laryngoscope, 126:1823–1830, 2016.

Original languageEnglish (US)
Pages (from-to)1823-1830
Number of pages8
Issue number8
StatePublished - Aug 1 2016


  • Angioedema
  • race
  • risk factors

ASJC Scopus subject areas

  • Otorhinolaryngology


Dive into the research topics of 'Case-control study evaluating competing risk factors for angioedema in a high-risk population'. Together they form a unique fingerprint.

Cite this